Prime Medicine

PRMENasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$642.074 M

$3.54 +10.97%

Close of 22 Sept 2026

Revenue

$4.63M

#3300 by revenue

Earnings

-$201.1M

Loss-making

Shares outstanding

181,376,856

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#57DBV TechnologiesDBVT$747.5M
#58Aura BiosciencesAURA$668.9M
#59Prime MedicinePRME$642.1M
#60Valneva SEVALN$625.3M
#61Ginkgo BioworksDNA$602.9M

What if Prime Medicine were worth as much as…

Open the what-if tool →

Gold $30.2T

$166,691.44

Per share 47,088× higher

Bitcoin $1.74T

$9,602.41

Per share 2,713× higher

Nvidia $5.52T

$30,410.53

Per share 8,591× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Prime Medicine are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.